Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group

Adams, 1996, Cannabis, Addiction, 91, 1585, 10.1111/j.1360-0443.1996.tb02264.x Adams, 1996, Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression, Lipids, 31, S157, 10.1007/BF02637069 Altamura, 1999, HPA-axis and cytokine dysregulation in schizophrenia, Eur Neuropsychopharmacol, 10, 1, 10.1016/S0924-977X(99)00017-6 American Psychiatric Association (1994): Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Press. Anderson, 1990, Docosahexaenoic acid is the preferred dietary ω-3 fatty acid for the development of the brain and retina, Pediatr Res, 27, 89, 10.1203/00006450-199001000-00023 Babin, 1993, Nervonic acid in red blood cell sphingomyelin in premature infants, Lipids, 28, 627, 10.1007/BF02536057 Bourre, 1992, Structural and functional importance of dietary polyunsaturated fatty acids in the nervous system, Adv Exp Med Biol, 318, 211, 10.1007/978-1-4615-3426-6_18 Bourre, 1989, The effects of dietary alpha-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning in rats, J Nutr, 119, 1880, 10.1093/jn/119.12.1880 Bourre, 1993, Dietary alpha-linolenic acid at 1,3 g/kg maintains maximal docosahexaenoic acid concentrations in brain, heart and liver of adult rats, J Nutr, 123, 1313, 10.1093/jn/123.7.1313 Brenner, 1991, Nutritional and hormonal factors influencing desaturation of essential fatty acids, Prog Lipid Res, 20, 41, 10.1016/0163-7827(81)90012-6 Carlson, 1986, High fat diets varying ratios of polyunsaturated to saturated fatty acids and linolenic acid, a comparison of rat neural and red cell membrane phospholipids, J Nutr, 116, 718, 10.1093/jn/116.5.718 Christensen, 1988, Fat consumption and schizophrenia, Acta Psychiatr Scand, 178, 587, 10.1111/j.1600-0447.1988.tb06388.x Cinti, 1993, The fatty acid elongation system of mammalian endoplasmatic reticulum, Prog Lipid Res, 31, 1, 10.1016/0163-7827(92)90014-A Connor, 1993, Is the docosahexaenoic acid (DHA 22:6.ω-3) content of erythrocytes a marker for the DHA content of brain phospholipids?, FASEB J, 7, 152 Dacremont, 1995, Measurement of very long-chain fatty acids, phytanic and pristanic acid in plasma and cultured fibroblasts by gas chromatography, J Inherit Metab Dis, 18, 76, 10.1007/BF00711430 Davidson, 1988, Essential fatty acids modulate apomorphine activity at dopamine receptors in cat caudate slices, Eur J Pharmacol, 149, 317, 10.1016/0014-2999(88)90662-0 Dawson, 1985, Enzymatic pathways of phospholipid metabolism in the nervous system, 45 Delion S, Chalon S, Herault J, Guilloteau D, Bernard JC, Durand G (1994): Chronic dietary alpha-linolenic acid deficiency alters dopaminergic and serotonergic neurotransmission in rats. J Nutr 124:2466–2435. Desvergne, 1999, Peroxisome proliferator-activated receptors, Endocr Rev, 20, 649 Doris, 1998, Red cell membrane fatty acids, cytosolic phospholipase-A2 and schizophrenia, Schizophr Res, 31, 185, 10.1016/S0920-9964(98)00016-4 Emrich, 1997, Towards a Cannabinoid hypothesis of schizophrenia, Pharmacol Biochem Behav, 56, 803, 10.1016/S0091-3057(96)00426-1 Feng, 1999, Dietary omega-3 polyunsaturated fatty acids reduce IFN-gamma receptor expression in mice, J Interferon Cytokine Res, 19, 41, 10.1089/107999099314405 Fenton, 2000, Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia, Biol Psychiatry, 47, 8, 10.1016/S0006-3223(99)00092-X Galli, 1971, Effects of dietary fatty acids on the fatty acid composition of brain ethanolamine phosphoglyceride, Biochim Biophys Acta, 248, 449, 10.1016/0005-2760(71)90233-5 Glen, 1996, Membrane fatty acids, niacin flushing and clinical parameters, Prostaglandins Leukot Essent Fatty Acids, 55, 9, 10.1016/S0952-3278(96)90139-8 Glen, 1994, A red cell membrane abnormality in a subgroup of schizophrenic patients, Schizophr Res, 12, 53, 10.1016/0920-9964(94)90084-1 Hagve, 1988, Regulation of the metabolism of polyunsaturated fatty acids, Scand J Clin Lab Invest, 48, 33, 10.1080/00365518809168292 Hibbeln, 1995, Dietary polyunsaturated fatty acids and depression, Am J Clin Nutr, 62, 1, 10.1093/ajcn/62.1.1 Hitzeman, 1984, Membrane abnormalities in the psychoses and affective disorders, J Psychiatr Res, 18, 319, 10.1016/0022-3956(84)90022-0 Holman, 1987, Human essential fatty acid deficiencies of dietary and metabolism origin, 215 Horrobin, 1995, Possible relevance of phospholipid and genetic interactions in psychiatric disorders, Med Hypotheses, 45, 605, 10.1016/0306-9877(95)90246-5 Horrobin, 1994, The membrane hypothesis of schizophrenia, Schizophr Res, 13, 195, 10.1016/0920-9964(94)90043-4 Horrobin, 1991, Fatty acid levels in the brains of schizophrenics and normal controls, Biol Psychiatry, 30, 795, 10.1016/0006-3223(91)90235-E Innis, 1991, Essential fatty acids in growth and development, Prog Lipid Res, 30, 39, 10.1016/0163-7827(91)90006-Q Jenski, 1998, The triggering signal dictates the effect of docosahexaenoic acid on lymphocyte function in vitro, Lipids, 33, 869, 10.1007/s11745-998-0283-x Katan, 1997, Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue, J Lipid Res, 38, 2012, 10.1016/S0022-2275(20)37132-7 Kay, 1987, The Positive and Negative Syndrome Scale (PANSS) for schizophrenia, Schizophr Bull, 13, 261, 10.1093/schbul/13.2.261 Kinsella, 1990, Lipids, membrane receptors, and enzymes, J Parenter Enteral Nutr, 14, 200S, 10.1177/014860719001400511 Laugharne, 1996, Fatty acids and schizophrenia, Lipids, 31, S163, 10.1007/BF02637070 Lee, 1993, Essential fatty acid deficiencies in parentally fed preterm infants, J Paediatr Child Health, 29, 51, 10.1111/j.1440-1754.1993.tb00440.x Linszen, 1994, Cannabis abuse and the course of recent-onset schizophrenia, Arch Gen Psychiatry, 51, 273, 10.1001/archpsyc.1994.03950040017002 Lord RS, Bralley JA. Clinical applications of fatty acid profiling. Available at: http://www.metametrix.com/articles/artcl_caf.htm. Accessed September 20, 2000. Maes, 1999, Lowered ω3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients, Psychiatry Res, 85, 275, 10.1016/S0165-1781(99)00014-1 Maes, 1997, Acute phase proteins in schizophrenia, mania and major depression, Psychiatry Res, 66, 1, 10.1016/S0165-1781(96)02915-0 Maes, 1996, Fatty acid composition in major depression, J Affect Disord, 38, 35, 10.1016/0165-0327(95)00092-5 Maes, 1998, Fatty acids, cytokines, and major depression, Biol Psychiatry, 43, 313 Mahadik, 1996, Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients, Psychiatry Res, 63, 133, 10.1016/0165-1781(96)02899-5 Mahadik, 1996, Utilization of precursor essential fatty acids in culture by skin fibroblasts from schizophrenic patients and normal controls, Prostaglandins Leukot Essent Fatty Acids, 55, 65, 10.1016/S0952-3278(96)90147-7 Malnoe, 1990, Effect of in vivo modulation of membrane docosahexaenoic acid levels on the dopamine-dependent adenylate cyclase activity in the rat retina, J Neurochem, 55, 1480, 10.1111/j.1471-4159.1990.tb04929.x Mazière, 1988, Trifluoperazine increases fatty acid turnover in phospholipids of cultured human fibroblasts, Lipids, 23, 419, 10.1007/BF02535513 Miller, 1992, Potentiation of NMDA receptor currents by arachidonic acid, Nature, 355, 722, 10.1038/355722a0 Montgomery, 1979, A new depression scale designed to be sensitive to change, Br J Psychiatry, 134, 328, 10.1192/bjp.134.4.382 Murray, 1992, A neurodevelopmental approach to the classification of schizophrenia, Schizophr Bull, 18, 319, 10.1093/schbul/18.2.319 Nabekura, 1998, Functional modulation of human recombinant gamma-aminobutyric acid type A receptor by docosahexaenoic acid, J Biol Chem, 273, 11056, 10.1074/jbc.273.18.11056 Netherlands Nutrient Database (1996): Nevo food composition table. The Hague: Nevo Foundation. Obi, 1979, Fatty acid profiles in mental disease, linolenate variations in schizophrenia, J Neurol Sci, 43, 447, 10.1016/0022-510X(79)90023-6 Okuyama, 1997, Dietary fatty acids—the n-6/n-3 balance and chronic elderly diseases, Prog Lipid Res, 35, 409, 10.1016/S0163-7827(96)00012-4 Pakala, 1999, Serotonin-induced endothelial cell proliferation is blocked by omega-3 fatty acids, Prostaglandins Leukot Essent Fatty Acids, 60, 115, 10.1054/plef.1998.0017 Pawlowski, 1999, The effects of cigarette smoking on the metabolism of essential fatty acids, Lipids, 34, S287, 10.1007/BF02562319 Peet, 1995, Depleted red cell membrane essential fatty acids in drug-treated schizophrenic patients, J Psychiatr Res, 29, 227, 10.1016/0022-3956(95)00001-L Peet, 1996, Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation, Prostaglandins Leukot Essent Fatty Acids, 55, 71, 10.1016/S0952-3278(96)90148-9 Peet, 1998, Depletion of omega-3 fatty acid levels in red blood cell membrane of depressive patients, Biol Psychiatry, 43, 315, 10.1016/S0006-3223(97)00206-0 Pettigrew, 1991, Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first episode drug-naive schizophrenics, Arch Gen Psychiatry, 48, 563, 10.1001/archpsyc.1991.01810300075011 Pies, 1998, Antipsychotics, 123 Piomelli, 1991, Dopamine activation of the arachidonic acid cascade as a basis for D1–D2 receptor synergism, Nature, 353, 164, 10.1038/353164a0 Puri, 1998, Sustained remission of positive and negative symptoms of schizophrenia following treatment with eicosapentaenoic acid, Arch Gen Psychiatry, 55, 188, 10.1001/archpsyc.55.2.188 Raederstorff, 1991, Hypothyroidism and thyroxin substitution affect the ω-3 fatty acid composition of rat liver mitochondria, Lipids, 26, 781, 10.1007/BF02536158 Ross, 1997, Increased phopholipid breakdown in schizophrenia, evidence for the involvement of a calcium-independent phopholipase A2, Arch Gen Psychiatry, 54, 487, 10.1001/archpsyc.1997.01830170113015 Ross, 1999, Differential alteration of phospholipase A2 in brain of patients with schizophrenia, Brain Res, 821, 407, 10.1016/S0006-8993(99)01123-3 Rotrosen, 1987, Phospholipid and prostaglandin hypotheses of schizophrenia, 759 Salem N Jr, Kim HY, Yergey JA (1986)): Docosahexaenoic acid membrane function and metabolism. In: Simopoulos A, Kaifer R, Martin R, editors: Handbook of Essential Fatty Acid Biology; Biochemistry, Physiology and Behavioral Neurobiology. Totowa, NJ: Humana, 397–426. Salem, 1995, The nervous system has an absolute molecular species requirement for proper function, Mol Membr Biol, 12, 131, 10.3109/09687689509038508 Sargent, 1994, Nervonic acid and demyelinating disease, Med Hypotheses, 42, 237, 10.1016/0306-9877(94)90122-8 Stanley, 1995, An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy, Arch Gen Psychiatry, 52, 399, 10.1001/archpsyc.1995.03950170073010 Stevens, 1972, The distribution of the phospholipid fractions in the red blood cell membrane of schizophrenics, Schizophr Bull, 6, 60, 10.1093/schbul/1.6.60 Szabo, 1983, Effects of neuroleptics on the lipid peroxidation and peroxide metabolism enzyme activities in various discrete areas of the rat brain, Gen Pharmacol, 14, 537, 10.1016/0306-3623(83)90116-7 Tocher, 1998, Recent advances in the biochemistry and molecular biology of fatty acyl desaturases, Prog Lipid Res, 37, 73, 10.1016/S0163-7827(98)00005-8 Vaddadi, 1996, Schizophrenia, tardive dyskinesia and essential fatty acids, Schizophr Res, 20, 287, 10.1016/0920-9964(95)00095-X Walker, 1999, Lipids and schizophrenia, Br J Psychiatry, 174, 101, 10.1192/bjp.174.2.101 Willats, 1998, Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving, Lancet, 353, 688, 10.1016/S0140-6736(97)11374-5 Williams, 1989, Arachidonic acid induces a long-term activity dependent enhancement of synaptic transmission in the hippocampus, Nature, 341, 739, 10.1038/341739a0 Yao, 1994, Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition, Schizophr Res, 13, 217, 10.1016/0920-9964(94)90045-0 Yao, 2000, Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients, Schizophr Res, 42, 7, 10.1016/S0920-9964(99)00095-X Yehuda, 1998, Fatty acids and brain peptides, Peptides, 19, 407, 10.1016/S0196-9781(97)00295-7